Fintel reports that on April 21, 2025, Wolfe Research upgraded their outlook for Intellia Therapeutics (NasdaqGM:NTLA) from ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room for improvement. A new ...

Farmers could soon start testing the effectiveness of gene-edited technology to control Spotted Winged Drosophila with ...

Taking note of this, Pia and his colleagues used the CRISPR-Cas9 technology, which targets SOX2. CRISPR-Cas9 is like a pair of scissors that can cut specific genes in DNA and is known to be able ...

ToolGen files patent infringement lawsuit against Vertex Pharma in UK for genome editing therapy CASGEVY: Seoul, South Korea Tuesday, April 22, 2025, 15:00 Hrs [IST] ToolGen, Inc.

As the demand for precision and efficiency in genetic research continues to grow, Creative Biogene's CRISPR library screening service stands out, allowing scientists to quickly identify and analyze ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

CASGEVY became the world's first genome editing therapy to receive marketing authorization, beginning with the United Kingdom ...

Trained in internal medicine and nephrology, Reshma once intended to teach, treat patients, and work in a lab after medical ...

Gain expert insights in this interview on achieving transfection success. Explore proven strategies to optimize your approach ...

In a significant nod to local innovation, President Yoweri Museveni has applauded Dr. Matthias Magoola, founder of Dei ...

Biomedical Research leads at USD 1.5 billion, supporting genetic discovery and translational research.